Pathological angiogenesis: mechanisms and therapeutic strategies

AC Dudley, AW Griffioen - Angiogenesis, 2023 - Springer
In multicellular organisms, angiogenesis, the formation of new blood vessels from pre-
existing ones, is an essential process for growth and development. Different mechanisms …

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

DM Smadja, QY Yue, R Chocron… - European …, 2021 - Eur Respiratory Soc
Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic phenotype
characterised by coagulopathy and endothelial dysfunction [1–4]. Following some cases of …

Vasculopathy in COVID-19

R Flaumenhaft, K Enjyoji… - Blood, The Journal of the …, 2022 - ashpublications.org
COVID-19 is a primary respiratory illness that is frequently complicated by systemic
involvement of the vasculature. Vascular involvement leads to an array of complications …

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

Q Ning, D Wu, X Wang, D Xi, T Chen, G Chen… - Signal transduction and …, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …

Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients

V Montiel, I Lobysheva, L Gerard, M Vermeersch… - …, 2022 - thelancet.com
Background SARS-CoV-2 targets endothelial cells through the angiotensin-converting
enzyme 2 receptor. The resulting endothelial injury induces widespread thrombosis and …

Increased VWF and decreased ADAMTS-13 in COVID-19: creating a milieu for (micro) thrombosis

EJ Favaloro, BM Henry, G Lippi - Seminars in thrombosis and …, 2021 - thieme-connect.com
von Willebrand factor (VWF) is a large adhesive multimeric protein involved in hemostasis.
The larger the size (or number of VWF multimers), the greater the functionality of the protein …

[HTML][HTML] COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management

P Li, Y Liu, Z Cheng, X Yu, Y Li - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …

Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection

IMB Francischetti, K Toomer, Y Zhang, J Jani… - …, 2021 - thelancet.com
Background SARS-CoV-2 infection is associated with thrombotic and microvascular
complications. The cause of coagulopathy in the disease is incompletely understood …

[HTML][HTML] Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications

Z Ma, KY Yang, Y Huang, KO Lui - Journal of Molecular and Cellular …, 2022 - Elsevier
The global propagation of SARS-CoV-2 leads to an unprecedented public health
emergency. Despite that the lungs are the primary organ targeted by COVID-19, systemic …